Literature DB >> 8027931

Comparison of the free radical-scavenging ability of captopril and ascorbic acid in an in-vitro model of lipid oxidation. Implications for reperfusion injury and ACE inhibitor therapy.

M J Kaufman1.   

Abstract

The free radical-scavenging activity of captopril and ascorbic acid was determined by assessing their ability to inhibit the peroxidation of linoleic acid in sodium dodecyl sulphate (SDS) micelles at 37 degrees C. The extent of peroxidation was monitored polarographically using an oxygen electrode to determine oxygen consumption rates. Ascorbic acid was observed to inhibit the peroxidation in a concentration-dependent fashion with an IC50 value of 17 microM. In contrast, the addition of captopril at concentrations up to 500 microM did not result in any detectable inhibition. Unlike ascorbic acid, no synergistic effect, as evidenced by the duration of inhibition, was observed with captopril/alpha-tocopherol mixtures. Measurements of the partitioning of captopril between SDS micelles and the aqueous phase show that 37% of the bulk captopril concentration is localized within the micellar phase; this indicates that phase separation of captopril from the lipid peroxyl radicals is not the cause of the observed lack of inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027931     DOI: 10.1111/j.2042-7158.1994.tb03782.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus.

Authors:  G O'Driscoll; D Green; J Rankin; K Stanton; R Taylor
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

2.  Cigarette smoking in men and vascular responsiveness.

Authors:  R Butler; A D Morris; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 3.  ACE inhibitors. Differential use in elderly patients with hypertension.

Authors:  Z H Israili; W D Hall
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.